Opendata, web and dolomites

PREDICT

PREDICT

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 PREDICT project word cloud

Explore the words cloud of the PREDICT project. It provides you a very rough idea of what is the project "PREDICT" about.

treatments    feasibility    transcranial    antidepressants    cover    ip    suicide    disorders    anti    prediction    software    citizens    stages    social    tool    light    patients    alternative    benefits    tools    invasive    depressed    clinics    technologies    options    suggested    accurate    electrophysiological    drug    health    solution    magnetic    psychiatric    decision    brain    potentially    operate    experiencing    diagnosis    expanded    professional    depression    clear    generate    mdd    economic    later    burden    eeg    life    impacts    people    freedom    improving    positively    clinical    researched    property    medical    patient    optimized    expectancy    stakeholders    elminda    providers    physicians    depressive    mental    informed    makers    disorder    stimulation    decisions    conventional    predict    shortage    reduce    tms    caused    updated    monitors    scope    treatment    personalize    optimizing    exploring    rates    service    intellectual    innovative    efficacy    disabilities    intends    good    clinicians    society    quality    framework    tackle    disruptive    adoption    depressant    supporting    time   

Project "PREDICT" data sheet

The following table provides information about the project.

Coordinator
ELMINDA LTD 

Organization address
address: Shenkar 1, WeWork Building
city: HERZLIYA
postcode: 4673314
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Israel [IL]
 Project website http://elminda.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.4. (Active ageing and self-management of health)
2. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.3.1.6. (Health care provision and integrated care)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-02-01   to  2018-07-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ELMINDA LTD IL (HERZLIYA) coordinator 50˙000.00

Map

 Project objective

Improving the current medical practice for mental health disorders such as depression, is a major concern for all stakeholders.The overall costs such as social and professional disabilities, increasing suicide rates, remain under-researched and their impacts are under-recognized by key decision-makers. In light of the economic and social burden caused by major depressive disorder (MDD), there is a strong need in the EU to provide citizens with adequate diagnosis and optimized treatment options. In this framework, PREDICT represents an innovative and disruptive tool; it is an EEG integrated software-based solution for physicians, which monitors brain electrophysiological activity with the scope of supporting and optimizing treatment decisions for depressed patients. The adoption of PREDICT in psychiatric clinics will positively affect patients, clinicians and it will potentially reduce costs for health service providers and for the whole society. Innovative technologies such as non-invasive Transcranial magnetic stimulation (TMS) offer a good alternative to the conventional antidepressants drug treatment. There is clear shortage in clinical PREDICTion tools which support better informed decisions and tackle the need to personalize the patient treatment. Our solution will provide a real-time, cost-effective method to assess TMS treatment efficacy and allow higher rates of treatment response. At later stages of product development, it will be expanded to cover PREDICTion to all available anti-depressant treatments. The suggested feasibility study will assess the overall economic benefits and will support ElMindA in exploring intellectual property opportunities through IP management and updated “Freedom to operate” analysis. By providing an accurate, simple to use cost-effective tool, our project intends to deliver an innovative solution that can generate a strong impact on society, increasing the quality of life and life expectancy of people experiencing major depression.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PREDICT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PREDICT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.4.;H2020-EU.2.1.1.;H2020-EU.2.3.1.;H2020-EU.3.1.6.)

CLINICOVERY (2018)

CLINICOVERY, a versatile, high quality, environmental-friendly, easy to use e-Clinical solution for clinical research

Read More  

ClearRing (2018)

An innovative, minimally invasive medical device used for treatment of Benign Prostatic Hyperplasia symptoms.

Read More  

JUMPAIR (2018)

Decubitus Ulcers Diseases Diagnoses by means of Smart ICT Anti-Decubitus System based on known Ulcers Activity Biomarkers

Read More